DNA Chip Research Balance Sheet Health
Financial Health criteria checks 6/6
DNA Chip Research has a total shareholder equity of ¥700.0M and total debt of ¥0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are ¥966.0M and ¥266.0M respectively.
Key information
0%
Debt to equity ratio
JP¥0
Debt
| Interest coverage ratio | n/a |
| Cash | JP¥462.00m |
| Equity | JP¥700.00m |
| Total liabilities | JP¥266.00m |
| Total assets | JP¥966.00m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 2397's short term assets (¥688.0M) exceed its short term liabilities (¥224.0M).
Long Term Liabilities: 2397's short term assets (¥688.0M) exceed its long term liabilities (¥42.0M).
Debt to Equity History and Analysis
Debt Level: 2397 is debt free.
Reducing Debt: 2397 has not had any debt for past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: Whilst unprofitable 2397 has sufficient cash runway for more than 3 years if it maintains its current positive free cash flow level.
Forecast Cash Runway: 2397 is unprofitable but has sufficient cash runway for more than 3 years, even with free cash flow being positive and shrinking by 3% per year.